Haemophilus influenza type b conjugate vaccine (Zhejiang Vacin Biomedicine)

b型流感嗜血杆菌结合疫苗（艾美卫信生物药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus influenza type b conjugate vaccine (Zhejiang Vacin Biomedicine)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHaemophilus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

Inactive CompaniesN/A

Active IndicationsHaemophilus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A